Skip to content
Open access

Enzymatic glycosylation and amidation reshapes polyene bioactivity

Jul 2026 · Nature · Vol 657, pp. 295 - 303 · 1 citation · 53 references
Medicine

TL;DR

Pathways to previously undescribed polyenes, including unusual enzymes that introduce more sugars onto polyene scaffolds, are discovered, and their accessibility through clean and efficient fermentation and potential for safe use as antifungal treatments is described.

Abstract

Fungal diseases are an escalating threat to human health, driven by rising antimicrobial resistance and a lack of new antifungal treatments1,2. Polyenes, a class of complex natural products, have been widely used as antifungal agents due to their broad-spectrum activity3. However, their clinical use is limited by severe toxicity and poor solubility, making safer and more effective alternatives urgently needed4. Previous efforts to generate improved polyenes have relied on costly, step-inefficient and atom-inefficient chemical syntheses5,6. Here we describe the discovery and characterization of pathways to previously undescribed polyenes, including unusual glycosyltransferase enzymes that introduce sugars onto polyene scaffolds. We also show how the reaction scope of an amidotransferase enzyme can be expanded to transform the detrimental carboxylate substituent of polyenes to alternative functionality. Introduction of a second sugar combined with carboxylate modifications leads to more potent polyene antifungals, with reduced toxicity, that are accessible by clean and efficient fermentation or enzymatic routes. Pathways to previously undescribed polyenes, including unusual enzymes that introduce more sugars onto polyene scaffolds, are discovered, and their accessibility through clean and efficient fermentation and potential for safe use as antifungal treatments is described.

Read PDF

Similar papers

Review Open access Aug 2026

Toward Complex Polyketide Biosynthesis in Yarrowia lipolytica via Metabolic Reprogramming

Polyketides are among the most structurally diverse and therapeutically important classes of natural products, serving as antibiotics, anticancer agents, agrochemicals, and industrial pigments. Their structural complexity and limited natural availability have driven the development of microbial biosynthetic platforms a...

Kian Ghaempanah, So-Hee Son, Ju-Young Lee · 0 citations
Open access Sep 2026

Directed biosynthesis of the designer peptidyl nucleoside antibiotics featuring a simplified azetidine-containing moiety

Fungal and fungal-like pathogen infections pose escalating threats to the global one-health, thus underscoring the urgent need to reverse this trend by accelerating the development of novel antifungal drugs. Polyoxin (POL), a group of structurally related nucleoside antibiotics, is an eco-friendly fungicide targeting f...

Rong Gong, Tianzhu Li, Li-Wei Zhou et al. · 0 citations
Aug 2026

Unlocking Microbial Access to Amino-substituted 4-Hydroxycoumarin Derivatives via Enzymatic Promiscuity and Metabolic Engineering.

Coumarins and their derivatives possess diverse bioactivities and broad applications in pharmaceuticals, food additives, and materials science. For example, amino-functionalized coumarin derivatives hold significant promise for the development of novel functional materials and drug discovery. However, the microbial bio...

Caiyi Zhao, Jing-Qi Hou, Daphne Huang et al. · 0 citations
Open access Sep 2026

Adenylation Domain Engineering Enables Biosynthesis of an Improved Polymyxin Antibiotic.

Polymyxins are potent nonribosomal peptide antibiotics, yet their clinical use is limited by a narrow therapeutic window and nephro-/neurotoxicity. Conventional efforts to improve these agents rely on the incorporation of nonnatural building blocks that cannot be accessed biosynthetically and therefore must be introduc...

Maximilian Müll, Pia Lanvers, Giulia Ravagnan et al. · 0 citations
Review Aug 2026

Isatin-based Strategies for Microbial Infections: A Multifaceted Perspective.

The therapeutic potential of isatin and its derivatives against bacterial, fungal, viral, and microbacterial diseases is well highlighted in this study.

Radhika Sharma, Manjot Singh, Pushp Kashyap et al. · 0 citations
Open access Aug 2026

Chemically triggered bioorthogonal activation of antimicrobial peptide mimic prodrugs

A novel AMP mimic prodrug where the cationic ammonium residues are caged with trans-cyclooctene units that can be bioorthogonally activated by tetrazine via an inverse-electron-demand Diels–Alder click-to-release reaction is developed, demonstrating the on-demand control of toxicity enabled by the bioorthogonal trigger...

Hao Luo, Rhiannon P. Kuchel, Kevin Neumann et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.